From the PhD to Equity Research Analyst
Interested in translating your science critical thinking skills to the market? Listen to Caroline Corner describe how she left the lab bench to break into the finance industry as an equity research analyst and consultant.
Published November 15, 2012
Caroline V. Corner, PhD
Consultant, Optio Biopharma Consulting
Caroline Corner, PhD, has been an equity research analyst since 2005, when she became a member of Wells Fargo Securities research team covering medical technology companies. Since leaving Wells Fargo, Caroline has been a Senior Equity Research Analyst at MLV & Company, Pacific Growth Equities, and Montgomery & Company, covering the medical device and diagnostics sectors, as well as regenerative medicine companies. Dr. Corner is currently working as a consultant, with clients in investment banking and academia. Prior to entering equity research, she held engineering and product development positions at Baxter Transfusion Therapies and Eli Lilly and Company. Caroline has a PhD in Biological and Environmental Engineering from Cornell University, where she also did graduate course work at the Johnson School of Business, and a BS in Biological Systems Engineering from Virginia Tech. Caroline is based in San Francisco.